166 related articles for article (PubMed ID: 10517345)
1. Schedule-dependent interactions between vinorelbine and paclitaxel in human carcinoma cell lines in vitro.
Kano Y; Akutsu M; Suzuki K; Ando J; Tsunoda S
Breast Cancer Res Treat; 1999 Jul; 56(1):79-90. PubMed ID: 10517345
[TBL] [Abstract][Full Text] [Related]
2. Schedule-dependent synergism and antagonism between paclitaxel and methotrexate in human carcinoma cell lines.
Kano Y; Akutsu M; Tsunoda S; Furuta M; Yazawa Y; Ando J
Oncol Res; 1998; 10(7):347-54. PubMed ID: 10063968
[TBL] [Abstract][Full Text] [Related]
3. Schedule-dependent interaction between paclitaxel and 5-fluorouracil in human carcinoma cell lines in vitro.
Kano Y; Akutsu M; Tsunoda S; Ando J; Matsui J; Suzuki K; Ikeda T; Inoue Y; Adachi K
Br J Cancer; 1996 Sep; 74(5):704-10. PubMed ID: 8795571
[TBL] [Abstract][Full Text] [Related]
4. Schedule-dependent synergism and antagonism between pemetrexed and paclitaxel in human carcinoma cell lines in vitro.
Kano Y; Akutsu M; Tsunoda S; Izumi T; Mori K; Fujii H; Yazawa Y; Mano H; Furukawa Y
Cancer Chemother Pharmacol; 2004 Dec; 54(6):505-13. PubMed ID: 15340759
[TBL] [Abstract][Full Text] [Related]
5. In vitro schedule-dependent interaction between paclitaxel and cisplatin in human carcinoma cell lines.
Kano Y; Akutsu M; Tsunoda S; Suzuki K; Yazawa Y
Cancer Chemother Pharmacol; 1996; 37(6):525-30. PubMed ID: 8612305
[TBL] [Abstract][Full Text] [Related]
6. Schedule-dependent interactions between paclitaxel and etoposide in human carcinoma cell lines in vitro.
Kano Y; Akutsu M; Suzuki K; Mori K; Yazawa Y; Tsunoda S
Cancer Chemother Pharmacol; 1999; 44(5):381-8. PubMed ID: 10501911
[TBL] [Abstract][Full Text] [Related]
7. In vitro schedule-dependent interaction between paclitaxel and SN-38 (the active metabolite of irinotecan) in human carcinoma cell lines.
Kano Y; Akutsu M; Tsunoda S; Mori K; Suzuki K; Adachi KI
Cancer Chemother Pharmacol; 1998; 42(2):91-8. PubMed ID: 9654107
[TBL] [Abstract][Full Text] [Related]
8. Schedule-dependent interaction between paclitaxel and doxorubicin in human cancer cell lines in vitro.
Akutsu M; Kano Y; Tsunoda S; Suzuki K; Yazawa Y; Miura Y
Eur J Cancer; 1995 Dec; 31A(13-14):2341-6. PubMed ID: 8652267
[TBL] [Abstract][Full Text] [Related]
9. Synergism of cytotoxic effects of vinorelbine and paclitaxel in vitro.
Budman DR; Calabro A; Wang LG; Liu XM; Stiel L; Adams LM; Kreis W
Cancer Invest; 2000; 18(8):695-701. PubMed ID: 11107439
[TBL] [Abstract][Full Text] [Related]
10. In vitro schedule-dependent interaction between irinotecan and vinorelbine in NCI H460 non-small cell lung cancer cell line.
Gauvin A; Bressolle F; Martineau P; Astre C; Pinguet F
Anticancer Res; 2002; 22(2A):905-12. PubMed ID: 12014670
[TBL] [Abstract][Full Text] [Related]
11. Combination paclitaxel and vinorelbine therapy: in vitro cytotoxic interactions and dose-escalation study in breast cancer patients previously exposed to anthracyclines.
Culine S; Roch I; Pinguet F; Romieu G; Bressolle F
Int J Oncol; 1999 May; 14(5):999-1006. PubMed ID: 10200354
[TBL] [Abstract][Full Text] [Related]
12. Drug interactions and cytotoxic effects of paclitaxel in combination with carboplatin, epirubicin, gemcitabine or vinorelbine in breast cancer cell lines and tumor samples.
Konecny G; Untch M; Slamon D; Beryt M; Kahlert S; Felber M; Langer E; Lude S; Hepp H; Pegram M
Breast Cancer Res Treat; 2001 Jun; 67(3):223-33. PubMed ID: 11561768
[TBL] [Abstract][Full Text] [Related]
13. In vitro search for synergy and antagonism: evaluation of docetaxel combinations in breast cancer cell lines.
Budman DR; Calabro A
Breast Cancer Res Treat; 2002 Jul; 74(1):41-6. PubMed ID: 12150451
[TBL] [Abstract][Full Text] [Related]
14. Schedule-dependent interaction between raltitrexed and 5-fluorouracil in human colon cancer cell lines in vitro.
Kano Y; Akutsu M; Suzuki K; Yazawa Y; Tsunoda S; Furukawa Y
Oncol Res; 2000; 12(3):137-48. PubMed ID: 11216672
[TBL] [Abstract][Full Text] [Related]
15. Schedule-dependent synergism and antagonism between raltitrexed ("Tomudex") and methotrexate in human colon cancer cell lines in vitro.
Kano Y; Akutsu M; Tsunoda S; Suzuki K; Yazawa Y; Furukawa Y
Jpn J Cancer Res; 2001 Jan; 92(1):74-82. PubMed ID: 11173547
[TBL] [Abstract][Full Text] [Related]
16. In vitro schedule-dependent interaction between paclitaxel and vinorelbine in A2780 parental and multidrug-resistant human ovarian cancer cell lines.
Roch I; Bressolle F; Pinguet F
Int J Oncol; 1997 Dec; 11(6):1379-85. PubMed ID: 21528349
[TBL] [Abstract][Full Text] [Related]
17. Pilot study of vinorelbine (Navelbine) and paclitaxel (Taxol) in patients with refractory breast cancer and lung cancer.
Chang AY; Garrow GC
Semin Oncol; 1995 Apr; 22(2 Suppl 5):66-70; discussion 70-1. PubMed ID: 7740336
[TBL] [Abstract][Full Text] [Related]
18. Effect of docetaxel with cisplatin or vinorelbine on lung cancer cell lines.
Aoe K; Kiura K; Ueoka H; Tabata M; Matsumura T; Chikamori M; Matsushita A; Kohara H; Harada M
Anticancer Res; 1999; 19(1A):291-9. PubMed ID: 10226557
[TBL] [Abstract][Full Text] [Related]
19. Re: Severe neurotoxicity in vinorelbine-paclitaxel combinations.
Budman DR; Weiselberg L; O'Mara V
J Natl Cancer Inst; 1997 Jan; 89(1):87-8. PubMed ID: 8978412
[No Abstract] [Full Text] [Related]
20. Schedule-dependent interactions between pemetrexed and cisplatin in human carcinoma cell lines in vitro.
Kano Y; Akutsu M; Tsunoda S; Izumi T; Kobayashi H; Inoue K; Mori K; Fujii H; Mano H; Odgerel T; Furukawa Y
Oncol Res; 2006; 16(2):85-95. PubMed ID: 16898269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]